Overview
Madoka Kuramitsu practices in Tokyo, Japan. Ms. Kuramitsu is rated as an Advanced expert by MediFind in the treatment of Pure Red Cell Aplasia. Her top areas of expertise are Adult T-Cell Leukemia, Aase Syndrome, Pure Red Cell Aplasia, and Leukemia.
Her clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Pure Red Cell Aplasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult T-Cell LeukemiaMs. Kuramitsu isElite. Learn about Adult T-Cell Leukemia.
- Advanced
- Aase SyndromeMs. Kuramitsu isAdvanced. Learn about Aase Syndrome.
- LeukemiaMs. Kuramitsu isAdvanced. Learn about Leukemia.
- Pure Red Cell AplasiaMs. Kuramitsu isAdvanced. Learn about Pure Red Cell Aplasia.
- Experienced
- AnemiaMs. Kuramitsu isExperienced. Learn about Anemia.
- Aplastic AnemiaMs. Kuramitsu isExperienced. Learn about Aplastic Anemia.
- Hemolytic Transfusion ReactionMs. Kuramitsu isExperienced. Learn about Hemolytic Transfusion Reaction.
- Transient Erythroblastopenia of ChildhoodMs. Kuramitsu isExperienced. Learn about Transient Erythroblastopenia of Childhood.